AlbireoPharma

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal GI and liver disease areas. The team has a broad experience in drug development and has an extensive network in the international scientific and clinical communities. Initiation of a Phase II Trial for A4250, the Companys Lead Compound for Cholestatic Liver Diseases and NASH. Go to news archive. Washington DC, May 15-19, 2015.

OVERVIEW

This domain albireopharma.com presently has a traffic classification of eight hundred and thirty-four thousand and fourteen (the smaller the better). We have researched zero pages within the web page albireopharma.com and found eight websites referencing albireopharma.com. We have noted one contacts and directions for albireopharma.com to help you communicate with them. This domain albireopharma.com has been online for eight hundred and ninety-five weeks, twenty-one minutes, forty-four seconds, and five hundred and seventy-five milliseconds.
Traffic Rank
#834014
Links to this site
8
Contacts
1
Locations
1
Online Since
May 2007

ALBIREOPHARMA.COM RANKINGS

This domain albireopharma.com is seeing fluctuating quantities of traffic throughout the the year. Astonishingly, the web site had a ranking in the past 24 hours of eight hundred and thirty-four thousand and fourteen.
Traffic for albireopharma.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for albireopharma.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for albireopharma.com

Date Range

All time
This Year
Last Year
Last Month

ALBIREOPHARMA.COM HISTORY

This domain albireopharma.com was first filed on May 07, 2007. This web site was updated on April 16, 2012. This site will expire on the date of May 06, 2015. It is now eight hundred and ninety-five weeks, twenty-one minutes, forty-four seconds, and five hundred and seventy-six milliseconds young.
REGISTERED
May
2007
UPDATED
April
2012
EXPIRED
May
2015

WEBSITE MATURITY

17
YEARS
1
MONTHS
28
DAYS

LINKS TO BUSINESS

Biodel Inc. - Life Delivered

Content on this page requires a newer version of Adobe Flash Player. Biodel to Report Fourth Quarter Fiscal Year 2013 Financial Results. It allows us to alter the pharmacokinetic profile, route of administration and stability of drugs that otherwise would be impractical to use as therapeutics because they break down too rapidly.

Välkommen till Läkemedelsförsäkringen

Om du inte är nöjd. Den som anser sig ha blivit skadad av ett läkemedel har rätt att vända sig till Läkemedelsförsäkringen för att få sin sak prövad. Om försäkringsgivarens utredning konstaterar godkänd läkemedelsskada kan anmälaren få ersättning. Att vända sig till Läkemedelsförsäkringen är ett för patienten enkelt och kostnadsfritt sätt att få sin skada reglerad. Alternativet är att vända sig till domstol och åberopa skadeståndslag.

WHAT DOES ALBIREOPHARMA.COM LOOK LIKE?

Desktop Screenshot of albireopharma.com Mobile Screenshot of albireopharma.com Tablet Screenshot of albireopharma.com

CONTACTS

Albireo AB

Jan Mattsson

Arvid Wallgrensbacke 20

Göteborg, 41346

SE

ALBIREOPHARMA.COM HOST

We caught that the main root page on albireopharma.com took nine thousand and eight milliseconds to download. We could not observe a SSL certificate, so therefore our web crawlers consider this site not secure.
Load time
9.008 seconds
SSL
NOT SECURE
Internet Address
212.247.68.217

NAME SERVERS

h05dns01.zitac.net
h05dns02.zitac.net

SERVER OPERATING SYSTEM

I observed that albireopharma.com is implementing the Microsoft-IIS/7.5 os.

TITLE

AlbireoPharma

DESCRIPTION

Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal GI and liver disease areas. The team has a broad experience in drug development and has an extensive network in the international scientific and clinical communities. Initiation of a Phase II Trial for A4250, the Companys Lead Compound for Cholestatic Liver Diseases and NASH. Go to news archive. Washington DC, May 15-19, 2015.

CONTENT

This domain states the following, "Albireo is an independent Swedish biotechnology company, which brings unique translational approaches to develop drugs that fulfil unmet medical needs in the gastrointestinal GI and liver disease areas." Our analyzers observed that the web page stated " The team has a broad experience in drug development and has an extensive network in the international scientific and clinical communities." The Website also stated " Initiation of a Phase II Trial for A4250, the Companys Lead Compound for Cholestatic Liver Diseases and NASH. Washington DC, May 15-19, 2015."

OTHER WEB PAGES

Albireos kennel Mittelspitz Ekeby

Favoritfärgen är vit som är sällsynt i Sverige. Har importerat min tik Undine aus dem Norden från Tyskland 2005. Har även haft uppfödning av samojed 1996-2006. Denna ras har jag haft sedan 1953. Vi bor i Ekeby, 20 km öster om Helsingborg. I bred Samoyeds betweeen 1996-2006. That breed has been in my life since 1953. Denna hemsida är byggd med N.

Albireo Topografía y Geomática

Deslindes de fincas rústicas y urbanas. Mediciones de fincas con estación total. Doctor Ingeniero en Geodesia, Cartografía y Sistemas de Información Geográfica. Colegiado 3773 Colegio Ingenieros Técnicos en Topografía. Perito judicial miembro de la Asociación de Peritos colaboradores con la Justicia de la Comunidad Valenciana.

アルビレックスチアリーダーズ Official Web Site

14期チアフェス Party on the floor.

新潟アルビレックスランニングクラブ公式サイト - Niigata Albirex RC Official WEBSITE

2組4着 高橋麻実 14 01 0. 地域の 元気 と 健康 を応援する 健菜御膳 第5弾を販売中です. デンカビッグスワンスタジアム 3時間 Fun Run リレーフェス 募集受付延長のお知らせ.